Corbus Pharmaceuticals Holdings (CRBP) Assets (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Assets of $168.2 million for Q4 2025, up 7.9% year-over-year from $155.9 million in Q4 2024, and up 53.58% quarter-over-quarter from $109.5 million in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Assets (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Assets history runs 13 years deep, the most recent figure standing at $168.2 million for Q4 2025.
- In Q4 2025, Assets rose 7.9% year-over-year to $168.2 million; the TTM figure through Dec 2025 stood at $168.2 million (up 7.9% YoY), while the FY2025 annual figure was $168.2 million, up 7.9% from the prior year.
- Assets for Q4 2025 stood at $168.2 million, up from $109.5 million in the prior quarter.
- The five-year high for Assets was $168.2 million in Q4 2025, with the low at $28.3 million in Q4 2023.
- The 5-year median for Assets is $114.5 million (2021), against an average of $105.3 million.
- The sharpest annual moves came in 2023 and 2024: Assets sank 57.37% in 2023, then surged 451.35% in 2024.
- Corbus Pharmaceuticals Holdings' Assets stood at $107.7 million in 2021, then sank by 38.45% to $66.3 million in 2022, then tumbled by 57.37% to $28.3 million in 2023, then soared by 451.35% to $155.9 million in 2024, then grew by 7.9% to $168.2 million in 2025.
- Business Quant data shows CRBP's Assets at $168.2 million in Q4 2025, $109.5 million in Q3 2025, and $125.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | 168.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 168.20 Mn |
| Sep 30, 2025 | 109.51 Mn |
| Jun 30, 2025 | 125.09 Mn |
| Mar 31, 2025 | 139.93 Mn |
| Dec 31, 2024 | 155.88 Mn |
| Sep 30, 2024 | 164.17 Mn |
| Jun 30, 2024 | 151.98 Mn |
| Mar 31, 2024 | 125.74 Mn |
| Dec 31, 2023 | 28.27 Mn |
| Sep 30, 2023 | 36.28 Mn |
| Jun 30, 2023 | 43.72 Mn |
| Mar 31, 2023 | 51.65 Mn |
| Dec 31, 2022 | 66.31 Mn |
| Sep 30, 2022 | 73.83 Mn |
| Jun 30, 2022 | 82.07 Mn |
| Mar 31, 2022 | 95.68 Mn |
| Dec 31, 2021 | 107.73 Mn |
| Sep 30, 2021 | 119.57 Mn |
| Jun 30, 2021 | 120.61 Mn |
| Mar 31, 2021 | 140.15 Mn |